Business Context and Reporting Period
OptimumBank Holdings, Inc. filed this Form 8-K on June 27, 2011, reporting events that occurred on June 21, 2011. The filing addresses regulatory compliance issues with The Nasdaq Stock Market following the resignation of Jerry Grace from the Company's board of directors on May 23, 2011.
Key Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes
The material change reported is the Company's failure to satisfy two specific Nasdaq listing rules due to the reduction in board composition:
- Audit Committee Composition: The Company now has only two audit committee members, failing the requirement for a minimum of three members with specific financial sophistication.
- Majority Independent Directors: The Company now has only two independent directors on a five-member board, failing the requirement for a majority of independent directors.
Outlook, Risks, and Contingencies
The Company faces potential delisting risks if it fails to regain compliance with Nasdaq rules within specified cure periods:
- Audit Committee Rule Cure Period: The Company has until the earlier of its next annual shareholders' meeting or May 23, 2012 (or November 21, 2011, if the meeting is held before that date) to regain compliance.
- Majority Independent Director Rule: The previous cure period was revoked. The Company has 45 days (until August 5, 2011) to submit a plan to regain compliance. If accepted, an exception may be granted for up to 180 days (until December 18, 2011). If the plan is rejected, the Company may appeal to a Hearings Panel.
- Management Action: The Company is actively seeking at least two qualified independent directors to fill the vacancies on the audit committee and the board.
Investor Verification Checklist
- Verify the timeline for the Company's next annual shareholders' meeting to determine the exact deadline for the Audit Committee Rule cure period.
- Monitor the submission of the compliance plan to Nasdaq by August 5, 2011.
- Confirm the appointment of new independent directors to restore the majority independent director status and audit committee composition.
- Check for any subsequent filings regarding the acceptance or rejection of the compliance plan by the Nasdaq Listing Qualifications Staff.